Nabriva Therapeutics, a bacterial infections focussed company, has named Francesco Maria Lavino as its chief commercial officer, it was reported on Thursday.

The new chief commercial officer joins the company from Merck & Co (MSD), bringing nearly two decades of pharmaceutical sales and marketing experience with expertise in anti-infective medications. Prior to serving MSD as its acting vice president, global brand leader anti-infective portfolio, he was vice president, international marketing for the anti-infectives portfolio at Cubist Pharmaceuticals. He has also held roles at UCB Pharma and 3M in Italy.

Colin Broom, chief executive officer of Nabriva, stated: "Francesco has the right experience and leadership qualities to build out a fully integrate commercial team and hospital field force in the US, and I am delighted to welcome him as part of our team."